Everolimus Pliva 5 mg tablete
| Name | Everolimus Pliva 5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-138283029 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 5 mg everolimusa |
| Pharmaceutical Form | tableta |
| Manufacturer | Teva Gyogyszergyar Zrt., Debrecen, Mađarska Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.09.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/116 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EG02 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
